Leaderboards/Pain Management and Opioid Use

Pain Management and Opioid Use

Last updated July 7, 2026

Rising Stars

New and hot

Rising Stars Researchers

S. Michaela Rikard

National Center for Injury Prevention and Control

Mike Fillon

National Cancer Institute

Octavia Amaechi

Spartanburg Regional Healthcare System

Universidad de Santiago de Chile

Sara E. Hallvik

Acumen (United States)

Yaswanth Kuthati

Cathay General Hospital

Elizabeth Salvo

University of Chicago

Mika Guzikevits

Hebrew University of Jerusalem

Rising Stars Papers

Sex bias in pain management decisions

Proceedings of the National Academy of Sciences|2024

66 cit.

PAR2 on oral cancer cells and nociceptors contributes to oral cancer pain that can be relieved by nanoparticle-encapsulated AZ3451

Biomaterials|2024

20 cit.

Trends in Naloxone Dispensing From Retail Pharmacies in the US

JAMA|2024

8 cit.

The Melatonin Type 2 Receptor Agonist IIK7 Attenuates and Reverses Morphine Tolerance in Neuropathic Pain Rats Through the Suppression of Neuroinflammation in the Spinal Cord

Pharmaceuticals|2024

8 cit.

Use of Heart Failure Medical Therapy Before and After a Cancer Diagnosis: A Longitudinal Study

ESC Heart Failure|2024

3 cit.

Awareness of and Beliefs About Naloxone Among Adults

JAMA Health Forum|2025

3 cit.

Results of the Family Medicine Journal Reviewer Demographic Survey

Family Medicine|2024

1 cit.

Inhibiting monoclonal antibody GDF‐15 improves cancer cachexia symptoms

CA A Cancer Journal for Clinicians|2025

1 cit.

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Diabetes Research and Clinical Practice|2025

1 cit.

A Rubric to Center Health Equity in Research

Family Medicine|2024

0 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

Lawrence Scholl

Centers for Disease Control and Prevention

Nicole L. Davis

Centers for Disease Control and Prevention

Lisa A. Gurski

National Comprehensive Cancer Network

Tamara M. Haegerich

National Institute on Drug Abuse

Veronica Zador

Cranbrook Academy of Art

Arya Nielsen

Icahn School of Medicine at Mount Sinai

Lesly A. Dossett

University of Michigan

Fondazione ISAL

Emerging Leaders Papers

Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

Journal of the National Comprehensive Cancer Network|2022

819 cit.

NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022

Journal of the National Comprehensive Cancer Network|2022

302 cit.

Bladder Cancer, Version 3.2024

Journal of the National Comprehensive Cancer Network|2024

236 cit.

NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024

Journal of the National Comprehensive Cancer Network|2024

215 cit.

Drug Overdose Deaths Among Persons Aged 10–19 Years — United States, July 2019–December 2021

MMWR Morbidity and Mortality Weekly Report|2022

166 cit.

NCCN Guidelines® Insights: Kidney Cancer, Version 2.2024

Journal of the National Comprehensive Cancer Network|2024

166 cit.

Implementation of Safe Supply Alternatives During Intersecting COVID-19 and Overdose Health Emergencies in British Columbia, Canada, 2021

American Journal of Public Health|2022

93 cit.

The practice and embodiment of “goofballs”: A qualitative study exploring the co-injection of methamphetamines and opioids

International Journal of Drug Policy|2022

46 cit.

De-escalation in breast cancer surgery

npj Breast Cancer|2022

42 cit.

Mothers Who Use Drugs: Closing the Gaps in Harm Reduction Response Amidst the Dual Epidemics of Overdose and Violence in a Canadian Urban Setting

American Journal of Public Health|2022

38 cit.

Current Senior Leaders

Established & currently active

Current Senior Leaders Researchers

Charles S. Cleeland

The University of Texas MD Anderson Cancer Center

Roger Chou

Brown University

Russell K. Portenoy

Albert Einstein College of Medicine

Éduardo Bruera

The University of Texas MD Anderson Cancer Center

Helsinki Art Museum

Philipps University of Marburg

Shuu‐Jiun Wang

National Yang Ming Chiao Tung University

Current Senior Leaders Papers

Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council

Journal of Pain|2016

3.1k cit.

A classification of chronic pain for ICD-11

Pain|2015

2.8k cit.

Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society

Annals of Internal Medicine|2007

2.7k cit.

CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016

MMWR Recommendations and Reports|2016

2.7k cit.

The Edmonton Symptom Assessment System (ESAS): A Simple Method for the Assessment of Palliative Care Patients

Journal of Palliative Care|1991

2.7k cit.

The use of coping strategies in chronic low back pain patients: Relationship to patient characteristics and current adjustment

Pain|1983

2.3k cit.

Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain

Journal of Pain|2009

2.2k cit.

Pain and Its Treatment in Outpatients with Metastatic Cancer

New England Journal of Medicine|1994

2k cit.

CDC Clinical Practice Guideline for Prescribing Opioids for Pain<b>—</b>United States, 2022

MMWR Recommendations and Reports|2022

1.7k cit.

The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress

European Journal of Cancer|1994

1.6k cit.

Reagents for Pain Management and Opioid Use

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 68

PathScan® Total Akt1 Chemiluminescent Sandwich ELISA Kit

#7132$66,129,740

View Evidence →

Cell Signaling TechnologyEvidence 65

Whitlow/218 Linker (E3U7Q) Rabbit Monoclonal Antibody (Alexa Fluor® 647 Conjugate)

#69310$5,131,466

View Evidence →

Cell Signaling TechnologyEvidence 67

Myc-Tag (9B11) Mouse Monoclonal Antibody (Pacific Blue™ Conjugate)

#64584$471

View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

SARS-CoV-2 Membrane Protein (E3V5H) Mouse Monoclonal Antibody

#32904$158,348

View Evidence →

Cell Signaling Technology

TACC3 (D9E4) Rabbit Monoclonal Antibody

CGRP antibody